MBBP Attorneys Sean Detweiler and Bill Schmidt to be Panelists for Intellectual Property Event

MBBP patent and trademark attorney Sean Detweiler and patent attorney Bill Schmidt are scheduled to be panelists for an upcoming event on March 23rd as they discuss "Intellectual Property: The Ins and Outs of Intellectual Property (IP)". Sean and Bill will be answering questions as they relate to Intellectual Property, specifically patents, in order to save people time and money by answering general …

Continue reading MBBP Attorneys Sean Detweiler and Bill Schmidt to be Panelists for Intellectual Property Event

MBBP Trademark Client FusionStorm Earns Ultra-Exclusive Dell EMC Titanium Black Honor

MBBP's trademark client FusionStorm has truly earned its stripes over the past six years after receiving more than a dozen Partner of the Year vendor awards, and recently having been handpicked as one of the partners to join the extremely exclusive Dell EMC Titanium Black program. This program gives FusionStorm access to a broad range …

Continue reading MBBP Trademark Client FusionStorm Earns Ultra-Exclusive Dell EMC Titanium Black Honor

MBBP’s Client Officeworks, and CEO Mark Loughlin, Expanding Into New York City

MBBP's client Officeworks, an office furniture dealership and consulting firm based in Boston, is expanding into the New York City office furniture market with current CEO Mark Loughlin and newly hired Principal David Quinn at the helm. Loughlin purchased the company in 2010, and sales began to skyrocket with growth being 10x what it had previously …

Continue reading MBBP’s Client Officeworks, and CEO Mark Loughlin, Expanding Into New York City

MBBP’s Client Abpro Collaborating with MedImmune on Medical Advancement

MBBP's client Abpro, a pioneer in the field of industrial biochemistry, has recently entered into a Collaboration Agreement with MedImmune, the global biologics research and development arm of AstraZeneca. The collaboration will advance the development of a preclinical, novel bispecific antibody targeting angiopoietin-2 and vascular endothelial growth factor (Ang2-VEGF). Abpro will contribute its strong scientific, technical and clinical expertise …

Continue reading MBBP’s Client Abpro Collaborating with MedImmune on Medical Advancement

MBBP Client Harvard Making Breakthroughs in Blood Stem Cell Research

Harvard University has recently completed a license agreement with Magenta Therapeutics, a newly launched start-up in Cambridge, Massachusetts, in order to continue research and development related to new approaches to blood stem cell transplantation. The deal will help transform this science from that of a "last resort" into safer, more effective therapy for patients who suffer from blood diseases, …

Continue reading MBBP Client Harvard Making Breakthroughs in Blood Stem Cell Research

MBBP’s Client Continuum Adding Innovative Solutions To Policy Matters To Its Company Profile

Continuum, a client of MBBP, has primarily focused on the design of innovative products since the company's founding in 1983. However, the organization is now delving into policy matters within the public sector, including public school education and public service employment. Continuum has come forth with a "radical new vision" for the Boston Redevelopment Authority, the …

Continue reading MBBP’s Client Continuum Adding Innovative Solutions To Policy Matters To Its Company Profile

Privacy & Data Security Video: Data Breach Response Requirements

In our sixth Privacy & Data Security video clip, attorney Sandy Kahn discusses the steps the law requires you to take if your company experiences a data breach. Make sure to subscribe to our YouTube channel and to check out our Privacy & Data Security playlist for related videos.

Harvard Stem Cell Institute Teaming Up to Develop Diabetes Cure

A group of Boston-area health institutions, known as the Boston Autologous Islet Replacement Program, are teaming up to develop, test and deploy stem cells to cure diabetes. The group includes the Harvard Stem Cell Institute, Brigham and Women's Hospital, the Joslin Diabetes Center, Dana-Farber Cancer Institute and Semma Therapeutics. The innovation began when Doug Melton, Co-Director …

Continue reading Harvard Stem Cell Institute Teaming Up to Develop Diabetes Cure

3/22/16 – On Your Mark. Get Set. GROW!

Join us in Waltham, MA on Tuesday, March 22 for a look at The Business Arc of a Sports Technology Startup. MBBP has teamed up with Boston Seed Capital to co-host a lively discussion on the unique experience of emerging companies in Boston's sports technology industry. Representatives from local sports tech startups Drivn and Fitivity will share a candid look …

Continue reading 3/22/16 – On Your Mark. Get Set. GROW!

“Watch” it here: MBBP Client WatchRx wins Boston Scientific Connected Patient Challenge!

MBBP client WatchRx, is an early stage startup founded while trying to help aging parents manage their medications and health conditions remotely. Current solutions available in the market, like mobile apps and pill caps/bottles, didn’t fit the need and only added to the confusion. WatchRx provides a a simple dedicated reminder solution. From voice reminders to GPS …

Continue reading “Watch” it here: MBBP Client WatchRx wins Boston Scientific Connected Patient Challenge!